Literature DB >> 10219334

Trends in infection morbidity in a pediatric oncology ward, 1986-1995.

G Wehl1, F Allerberger, A Heitger, B Meister, K Maurer, F M Fink.   

Abstract

BACKGROUND AND PROCEDURE: We retrospectively studied the type, severity, frequency, and outcome of febrile infectious complications in 217 cancer patients receiving cytotoxic chemotherapy (603 episodes) over a 10-year period in a single pediatric institution.
RESULTS: A total of 48.8% of the episodes occurred in severely leukopenic patients (WBC < 1.0 x 10(9)/l, absolute neutrophil count < 500 x 10(6)/l). In the second half of the study period febrile episodes occurred at increased frequency. The number of patients with gram-positive isolates in blood cultures increased over the years, most frequently coagulase-negative staphylococci were found. Remarkably, gram-negative bacteria increasingly resistant to the administered first-line antibiotic regimen emerged, necessitating modifications of the antimicrobial strategy every 3 years. Furthermore, Clostridium difficile-associated enterocolitis posed a clinical problem at increasing frequency since 1993. As expected, the speed of leukocyte recovery within 5 days from the onset of a febrile complication had an influence on the outcome of these episodes.
CONCLUSIONS: Rapid recovery of the WBC was associated with an excellent prognosis whereas persisting neutropenia was found to be a negative factor associated with fatal outcomes. The fatality rate of all febrile episodes (2.3%) remained the same throughout the study period despite the availability and wider use of recombinant hematopoietic growth factors since 1991.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10219334     DOI: 10.1002/(sici)1096-911x(199905)32:5<336::aid-mpo5>3.0.co;2-4

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  8 in total

1.  [Bacteraemia risk criteria in the paediatric febrile neutropenic cancer patient].

Authors:  Sandra Gala Peralta; Teresa Cardesa Salzman; Juan José García García; Jesús Estella Aguado; Amadeu Gené Giralt; Carles Luaces Cubells
Journal:  Clin Transl Oncol       Date:  2005-05       Impact factor: 3.405

2.  Clostridium difficile-associated disease in children with solid tumors.

Authors:  Elio Castagnola; Teresa Battaglia; Roberto Bandettini; Ilaria Caviglia; Ivana Baldelli; Marilina Nantron; Cristina Moroni; Alberto Garaventa
Journal:  Support Care Cancer       Date:  2008-09-19       Impact factor: 3.603

3.  Infections in a pediatric patient cohort with acute lymphoblastic leukemia during the entire course of treatment.

Authors:  Katerina Katsimpardi; Vassilios Papadakis; Anastasia Pangalis; Agapi Parcharidou; John P Panagiotou; Michael Soutis; Evangelos Papandreou; Sophia Polychronopoulou; Stavros Haidas
Journal:  Support Care Cancer       Date:  2005-11-04       Impact factor: 3.603

4.  Fecal fungal flora of pediatric healthy volunteers and immunosuppressed patients.

Authors:  H Agirbasli; S A Keceli Ozcan; Gündüz Gedikoğlu
Journal:  Mycopathologia       Date:  2005-06       Impact factor: 2.574

5.  Immune System Dysfunction Criteria in Critically Ill Children: The PODIUM Consensus Conference.

Authors:  Mark W Hall; Joseph A Carcillo; Timothy Cornell
Journal:  Pediatrics       Date:  2022-01-01       Impact factor: 9.703

6.  Fever in neutropenia in children and adolescents: evolution over time of main characteristics in a single center, 1993-2001.

Authors:  Roland A Ammann; Christoph Aebi; Andreas Hirt; Annette Ridolfi Lüthy
Journal:  Support Care Cancer       Date:  2004-07-08       Impact factor: 3.603

7.  Neutropenic enterocolitis in children with acute leukemia or aplastic anemia.

Authors:  Bulent Alioglu; Zekai Avci; Figen Ozcay; Serdar Arda; Namik Ozbek
Journal:  Int J Hematol       Date:  2007-11       Impact factor: 2.490

8.  Which Type of Empiric Antibiotic Therapy is Appropriate? A 20-Year Retrospective Study of Bloodstream Infections in Childhood Cancer.

Authors:  Andreas Meryk; Gabriele Kropshofer; Caroline Bargehr; Miriam Knoll; Benjamin Hetzer; Cornelia Lass-Flörl; Roman Crazzolara
Journal:  Infect Dis Ther       Date:  2021-03-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.